These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15773535)

  • 1. Hydrocortisone butyrate 0.1% cream in the treatment of chronic dermatitis.
    Fowler JF; Fransway AF; Jackson JM; Rohowsky N
    Cutis; 2005 Feb; 75(2):125-31. PubMed ID: 15773535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, multicenter trial comparing fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, applied twice daily for 4 weeks in the treatment of psoriasis.
    James M
    Cutis; 2001 Apr; 67(4 Suppl):2-9. PubMed ID: 11338723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrocortisone 17-butyrate (Locoid) 0.1% fatty cream versus desonide (Apolar) 0.1% ointment in the treatment of patients suffering from atopic dermatitis.
    Rajka G; Verjans HL
    J Int Med Res; 1986; 14(2):85-90. PubMed ID: 3516754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrocortisone 17-butyrate (Locoid) 0.1% cream versus hydrocortisone (Uniderm) 1% cream in the treatment of children suffering from atopic dermatitis.
    Veien NK; Hattel T; Justesen O; Nørholm A; Verjans HL
    J Int Med Res; 1984; 12(5):310-3. PubMed ID: 6389217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial.
    Meurer M; Eichenfield LF; Ho V; Potter PC; Werfel T; Hultsch T
    J Dermatolog Treat; 2010 May; 21(3):157-66. PubMed ID: 20394491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: mometasone furoate study group.
    Lebwohl M
    Int J Dermatol; 1999 Aug; 38(8):604-6. PubMed ID: 10487451
    [No Abstract]   [Full Text] [Related]  

  • 7. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis.
    De Belilovsky C; Roo-Rodriguez E; Baudouin C; Menu F; Chadoutaud B; Msika P
    J Dermatolog Treat; 2011 Dec; 22(6):359-65. PubMed ID: 20964572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
    Spergel JM; Boguniewicz M; Paller AS; Hebert AA; Gallagher PR; McCormick C; Parneix-Spake A; Hultsch T
    Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects.
    Matheson R; Kempers S; Breneman D; Draelos Z; Johnson CE; Loss R; Hogan DJ; Schoenfeld R; Checketts S; Kircik L; Fivenson D; Hebert AA; Williams J; Hamlin R; Groisser D; Piacquadio D
    J Drugs Dermatol; 2008 Mar; 7(3):266-71. PubMed ID: 18380208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.
    Belsito DV; Fowler JF; Marks JG; Pariser DM; Hanifin J; Duarte IA; Pires MC; Cruz PD; Langley RG; Patel P; Bush C; Thurston M; Graeber M; Cherill R;
    Cutis; 2004 Jan; 73(1):31-8. PubMed ID: 14964629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
    O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis.
    Meurer M; Fartasch M; Albrecht G; Vogt T; Worm M; Ruzicka T; Altmeyer PJ; Schneider D; Weidinger G; Braeutigam M;
    Dermatology; 2004; 208(4):365-72. PubMed ID: 15178928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of alclometasone dipropionate cream 0.05% with hydrocortisone butyrate cream 0.1% in the treatment of atopic dermatitis in children.
    Lassus A
    J Int Med Res; 1983; 11(5):315-9. PubMed ID: 6357892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis.
    Griffiths CE; Van Leent EJ; Gilbert M; Traulsen J;
    Br J Dermatol; 2002 Aug; 147(2):299-307. PubMed ID: 12174103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema.
    Juhlin L
    Cutis; 1996 Feb; 57(2 Suppl):51-6. PubMed ID: 8646871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.